GET and interaction assays link a leukemia-risk PAX5 variant to stronger NR2C2 binding
The General Expression Transformer (GET) model inferred cell-type-specific transcription-factor motif interactions from regulatory data and nominated a lymphocyte-specific interaction between PAX5 and nuclear-receptor-family factors. AlphaFold multimer modeling and PAX5 proximity-labeling in a B-ALL cell line supported interaction with NR2C2; the leukemia-associated PAX5 G183S variant showed increased PAX5–NR2C2 proximity signal. The variant-specific expression profile was enriched for predicted NR/3 and shared PAX5/NR/3 target genes, suggesting a possible regulatory mechanism for the germline risk variant.
Technology: GET (General Expression Transformer) foundation model for cell-type-specific regulatory grammar; AlphaFold2/AlphaFold Multimer for structural hypothesis assessment
Family AlphaFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The General Expression Transformer (GET) model inferred cell-type-specific transcription-factor motif interactions from regulatory data and nominated a lymphocyte-specific interaction between PAX5 and nuclear-receptor-family factors.
- Still unknown: This is a cell-line interaction and expression analysis, not proof that the variant causes leukemia or directly alters disease risk through NR2C2. PAX5–NR2C2 interaction itself was consistent with prior evidence for the paralogue PAX2 and mouse pre-B cells; the specific reported distinction is increased interaction signal with PAX5 G183S and associated transcriptional enrichment. The authors call the disease-driving mechanism possible and identify limitations in cell-state and variant resolution.
- AI role: GET learned regulatory syntax across 213 cell types and used motif co-regulation to predict TF–TF interactions, which nominated PAX5/nuclear receptor family interactions in B cells. Structural modeling prioritized candidate binding interfaces. Researchers then used proximity labeling and mass spectrometry in a B-ALL cell line to compare wild-type PAX5 with the G183S leukemia-risk variant.
Evidence sources: https://www.nature.com/articles/s41586-024-08391-z.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 156 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.